Tango Therapeutics, Inc. announced that Kanishka Pothula, a partner at Nextech Ventures, was appointed to the Company's Board of Directors. Previously, Mr. Pothula spent over 10 years with BVF Partners. He holds a B.S. in bioengineering from the University of California San Diego and an M.S. in biotechnology from Georgetown University.

Reid Huber, Ph.D., a partner at Third Rock Ventures, stepped down from his role on the Board of Directors.